SCHEMBL658097

SCHEMBL658097

O=C(CBr)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11606690 0.89 GSK3B (0.68)
SCHEMBL11606933 0.88 ALDH1A1 (0.55)
SCHEMBL11607360 0.88 GSK3B (0.56)
Tetrachlorothiophene SCHEMBL11605619 0.86 GSK3B (0.54)
SCHEMBL10352206 0.83 ALDH1A1 (0.77)
SCHEMBL2216212 0.82 ALDH1A1 (1.00)
SCHEMBL711360 0.82 RAB9A (0.75)
SCHEMBL11682516 0.81 ALDH1A1 (0.47)
SCHEMBL12603814 0.80 ALDH1A1 (0.71)
SCHEMBL23855456 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 609 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117050051-B Purification method of 2-bromo-1- (5-iodothiophene-2-yl) -ethanone Shanghai yaotan pharmaceutical research and Development Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-118930487-A 1,3, 5-Trisubstituted pyrazole compound and preparation method thereof 赣南师范大学 2024-11-12 CN claimed
CN-117050051-A Purification method of 2-bromo-1- (5-iodothiophene-2-yl) -ethanone 上海药坦药物研究开发有限公司 2023-11-14 CN claimed
US-20200190513-A1 METHODS AND SYSTEMS FOR ANALYZING GUIDE RNA MOLECULES EDITAS MEDICINE, INC. (US) 2020-06-18 US claimed
EP-3615672-A1 METHODS AND SYSTEMS FOR ANALYZING GUIDE RNA MOLECULES Editas Medicine, Inc. (US) 2020-03-04 EP claimed
EP-3565895-A1 SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO Editas Medicine, Inc. (US) 2019-11-13 EP claimed
WO-2018201086-A1 METHODS AND SYSTEMS FOR ANALYZING GUIDE RNA MOLECULES EDITAS MEDICINE, INC. (US) 2018-11-01 WO claimed
WO-2018126176-A1 SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO EDITAS MEDICINE, INC. (US) 2018-07-05 WO claimed
US-20110288315-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND DAISO CO., LTD. (JP) 2011-11-24 US claimed
EP-2325178-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND DAISO CO., LTD. (JP) 2011-05-25 EP claimed
EP-1243581-B1 Pyridinium compounds useful for the treatment of AGE-related diseases TORRENT PHARMACEUTICALS LTD (IN) 2005-07-13 EP claimed
EP-1404681-A1 PROCESS FOR THE PREPARATION OF TETRAHYDROTHIENO [3,2-C] PYRIDINE DERIVATIVES Brantford Chemicals Inc. (CA) 2004-04-07 EP claimed
US-6608094-B2 Breaking preformed AGE TORRENT PHARMACEUTICALS LTD. (IN) 2003-08-19 US claimed
WO-2003004502-A1 PROCESS FOR THE PREPARATION OF TETRAHYDROTHIENO [3,2-C] PYRIDINE DERIVATIVES BRANTFORD CHEMICALS INC. (CA) 2003-01-16 WO claimed
US-6495691-B1 THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, WHEREIN THE MEANING OF X IS HYDROGEN, CARBOXYL, ALKOXYCARBONYL, ARYLOXYCARBONYL, NITRILE, OR CARBAMOYL OF THE FORMULA TICLOPIDINE, IS AN ANTITHROMBOTIC DRUG WITH PLATELET AGGREGATION INHIBITING BRANTFORD CHEMICALS INC. (CA) 2002-12-17 US claimed
CN-117050051-B Purification method of 2-bromo-1- (5-iodothiophene-2-yl) -ethanone Shanghai yaotan pharmaceutical research and Development Co.,Ltd. (CN) 2026-05-26 CN disclosed
EP-4731216-A1 HETEROARYL-AMINE COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS Augustine Therapeutics (BE) 2026-04-29 EP disclosed
US-4024156-A Thiophene ethanolamines AMERICAN HOME PRODUCTS CORPORATION (US) 1977-05-17 US disclosed
US-4017631-A MICROBIOCIDES JANSSEN PHARMACEUTICA N.V. (BE) 1977-04-12 US disclosed
US-3991202-A ANTIMICROBIALS JANSSEN PHARMACEUTICA N.V. (BE) 1976-11-09 US disclosed